Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-03 · accession 0000950170-24-026098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-03-05 | 2024-03-04 | TEVA | Conway Vikki L | See "Remarks" | S - Sale+OE | $13.37 | -3,532 | 6,617 | -35% | -$47.2K |
| DMT | 2024-03-05 | 2024-03-03+ | TEVA | Conway Vikki L | See "Remarks" | M - OptEx | — | +12.3K | 8,107 | New | — |
| DMT | 2024-03-05 | 2024-03-03+ | TEVA | Conway Vikki L | See "Remarks" | M - OptEx | $0.00 | -12.3K | 14.2K | -46% | $0 |
| DT | 2024-03-05 | 2024-03-04 | TEVA | Conway Vikki L | See "Remarks" | A - Grant | $0.00 | +33.5K | 33.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-03-04 | S | D | 2,042 | $13.37 | 11,692 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F4) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II. (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.445, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Ordinary Shares | 2024-03-04 | M | A | 7,117 | — | 13,734 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 3 | Common | Ordinary Shares | 2024-03-04 | S | D | 1,490 | $13.37 | 6,617 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F4) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II. (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.445, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Ordinary Shares | 2024-03-03 | M | A | 5,179 | — | 8,107 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 5 | Derivative | Restricted Share Units | 2024-03-03 | M | D | 5,179 | $0.00 | 15,538 | D | — · — to — | 5,179 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F6) Restricted share units were granted on March 3, 2023, with 5,179 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 5,180 vesting on March 3, 2027. |
| 6 | Derivative | Restricted Share Units | 2024-03-04 | M | D | 7,117 | $0.00 | 14,237 | D | — · — to — | 7,117 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F7) Restricted share units were granted on March 4, 2022, with 7,117 vesting on each of March 4, 2024 and March 4, 2025, and 7,120 vesting on March 4, 2026. |
| 7 | Derivative | Restricted Share Units | 2024-03-04 | A | A | 33,482 | $0.00 | 33,482 | D | — · — to — | 33,482 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F8) Restricted share units were granted on March 4, 2024, with 8,370 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 8,372 vesting on March 4, 2028. |